104 related articles for article (PubMed ID: 1963759)
1. [An effective case of M-VAC therapy of advanced bladder cancer with extramammary Paget's disease].
Miyamoto H; Iizawa H; Takahashi T; Miura T; Kinoshita Y; Kubota Y; Hosaka M
Hinyokika Kiyo; 1990 Dec; 36(12):1459-62. PubMed ID: 1963759
[TBL] [Abstract][Full Text] [Related]
2. [Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report].
Hatano K; Kawashima A; Arai Y; Inoue H; Miyagawa Y; Takaha N; Nishimura K; Miyake O; Okuyama A
Hinyokika Kiyo; 2006 Oct; 52(10):801-3. PubMed ID: 17131872
[TBL] [Abstract][Full Text] [Related]
3. [A case of carcinomatous meningitis from transitional cell carcinoma of the urinary bladder].
Hara Y; Kobayashi Y; Goto K; Tozuka K; Tokue A; Mochizuki M
Hinyokika Kiyo; 1994 Dec; 40(12):1113-7. PubMed ID: 7863865
[TBL] [Abstract][Full Text] [Related]
4. [A case of genital Paget's disease with severe dermal invasion and early dissemination].
Iwamura H; Horii Y; Tokuchi H; Arai E
Hinyokika Kiyo; 1999 Apr; 45(4):281-4. PubMed ID: 10363152
[TBL] [Abstract][Full Text] [Related]
5. [Complete remission of brain metastasis of bladder cancer treated by M-VAC therapy].
Nakagawa S; Nakao M; Toyoda K; Nukui M; Takada H; Ebisui K
Hinyokika Kiyo; 1989 Feb; 35(2):333-5. PubMed ID: 2735244
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
7. [Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity].
Rassweiler J; Rüther U; Bäuerle K; Bub P; Jipp P; Eisenberger F
Urologe A; 1989 Jan; 28(1):25-30. PubMed ID: 2922897
[TBL] [Abstract][Full Text] [Related]
8. [A case of right renal pelvic and ureter cancer with hepatic metastasis showing complete response by M-VAC].
Sumiyoshi Y; Akiyama K; Yano M
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1521-3. PubMed ID: 2389946
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.
Sternberg CN; Yagoda A; Scher HI
Prog Clin Biol Res; 1988; 277():45-51. PubMed ID: 3054909
[No Abstract] [Full Text] [Related]
10. [Usefulness of magnetic resonance imaging for evaluation of therapeutic efficacy of bone metastases from bladder cancer: a case report].
Urushibara M; Tsukamoto T; Horiuchi S; Negishi T
Hinyokika Kiyo; 1998 Jul; 44(7):501-3. PubMed ID: 9752607
[TBL] [Abstract][Full Text] [Related]
11. [Experience with combination chemotherapy consisting of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer].
Nishio Y; Shirahase T; Shichiri Y; Habuchi T; Matsuda T; Nishimura K; Hida S; Okada Y; Yoshida O
Hinyokika Kiyo; 1988 Aug; 34(8):1371-5. PubMed ID: 3195405
[TBL] [Abstract][Full Text] [Related]
12. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
Keating JP; Zincke H; Hahn RG; Morgan WR
Prog Clin Biol Res; 1990; 353():119-27. PubMed ID: 2217409
[No Abstract] [Full Text] [Related]
13. [A case of lung metastases of bladder cancer in which thoracotomy was performed following M-VAC therapy].
Masuda M; Hujii Y; Hirokawa M; Hasegawa H; Kido Y; Matsushita K
Hinyokika Kiyo; 1990 Oct; 36(10):1181-4. PubMed ID: 2264546
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer].
Sella A; Flex D; Gafni D; Rabinovitz O; Sulkes A; Baniel J
Harefuah; 1999 Feb; 136(4):268-71, 340, 339. PubMed ID: 10914214
[TBL] [Abstract][Full Text] [Related]
16. [A case of primary transitional cell carcinoma of the prostate].
Konya E; Nose K; Kiwamoto H; Kataoka K; Kajikawa H; Kurita T
Hinyokika Kiyo; 1999 Jun; 45(6):439-42. PubMed ID: 10442290
[TBL] [Abstract][Full Text] [Related]
17. [M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].
Igawa M; Ueki T; Ueda M; Okada K; Usui T; Ohnishi Y; Nakatsu H; Kume T; Kodama M; Masu C
Hinyokika Kiyo; 1989 Aug; 35(8):1323-7. PubMed ID: 2683648
[TBL] [Abstract][Full Text] [Related]
18. [M-VAC chemotherapy for advanced urothelial cancer--side effects and their management].
Noguchi S; Kubota Y; Shuin T; Masuda M; Misaki H; Yao M; Kondoh K; Sakuramoto T; Hosaka M
Hinyokika Kiyo; 1994 Aug; 40(8):677-82. PubMed ID: 7942364
[TBL] [Abstract][Full Text] [Related]
19. M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.
Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Watson RC; Hollander PS; Fair WR
Prog Clin Biol Res; 1988; 260():481-5. PubMed ID: 3283768
[No Abstract] [Full Text] [Related]
20. [Neoadjuvant chemotherapy (M-VAC) in invasive cancer of the bladder. Our experience].
González Enguita C; Caro Cebrián C; Roncalés Badal A; Gil Sanz MJ; Martínez Bengoechea J; Rioja Sanz LA
Arch Esp Urol; 1990; 43 Suppl 2():197-204. PubMed ID: 2096779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
